OPK (STOCKS)
Opko Health Inc.
$1.150100
-0.009900 (-0.85%)
Prev close: $1.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Phillip Frost
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $895.70M
- Employees
- 2,997
- P/E (TTM)
- -3.87
- P/B (TTM)
- 0.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.04 | $-0.07 | +0.0293 | +42.28% |
|
Sep 2025 (Q3)
|
$0.03 | $-0.05 | +0.0755 | +165.93% |
|
Jun 2025 (Q2)
|
$-0.19 | $-0.11 | -0.0755 | -65.94% |
|
Mar 2025 (Q1)
|
$-0.10 | $-0.07 | -0.0307 | -44.30% |
Financial Statements
| Revenues | $606.88M |
| Benefits Costs and Expenses | $848.24M |
| Cost Of Revenue | $400.94M |
| Costs And Expenses | $724.29M |
| Gross Profit | $205.94M |
| Nonoperating Income/Loss | -$123.96M |
| Operating Expenses | $323.35M |
| Selling, General, and Administrative Expenses | $223.00M |
| Research and Development | $124.03M |
| Operating Income/Loss | -$117.41M |
| Income/Loss Before Equity Method Investments | -$241.36M |
| Income/Loss From Continuing Operations After Tax | -$225.65M |
| Income/Loss From Continuing Operations Before Tax | -$241.36M |
| Income/Loss From Equity Method Investments | -$29.00K |
| Income Tax Expense/Benefit | -$15.71M |
| Income Tax Expense/Benefit, Current | -$714.00K |
| Income Tax Expense/Benefit, Deferred | -$15.00M |
| Interest Expense, Operating | $0.00 |
| Net Income/Loss | -$225.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$225.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$225.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.30 |
| Diluted Earnings Per Share | -$0.30 |
| Basic Average Shares | 751,132,891 |
| Diluted Average Shares | 751,132,891 |
| Assets | $1.93B |
| Current Assets | $581.88M |
| Inventory | $65.82M |
| Other Current Assets | $516.06M |
| Noncurrent Assets | $1.35B |
| Fixed Assets | $73.93M |
| Intangible Assets | $516.28M |
| Other Non-current Assets | $759.86M |
| Liabilities | $663.99M |
| Current Liabilities | $146.68M |
| Accounts Payable | $41.10M |
| Other Current Liabilities | $105.57M |
| Noncurrent Liabilities | $517.31M |
| Long-term Debt | $343.97M |
| Other Non-current Liabilities | $173.34M |
| Equity | $1.27B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.27B |
| Liabilities And Equity | $1.93B |
| Net Cash Flow From Operating Activities | -$178.54M |
| Net Cash Flow From Operating Activities, Continuing | -$178.54M |
| Net Cash Flow From Investing Activities | $230.30M |
| Net Cash Flow From Investing Activities, Continuing | $230.30M |
| Net Cash Flow From Financing Activities | -$118.06M |
| Net Cash Flow From Financing Activities, Continuing | -$118.06M |
| Net Cash Flow | -$66.30M |
| Net Cash Flow, Continuing | -$66.30M |
| Comprehensive Income/Loss | -$190.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$190.57M |
| Other Comprehensive Income/Loss | -$190.57M |
| Other Comprehensive Income/Loss Attributable To Parent | $35.11M |